These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1692254

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells.
    Skalski V, Yarosh DB, Batist G, Gros P, Feindel W, Kopriva D, Panasci LC.
    Mol Pharmacol; 1990 Sep; 38(3):299-305. PubMed ID: 2402223
    [Abstract] [Full Text] [Related]

  • 4. Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.
    Noë AJ, Malapetsa A, Panasci LC.
    Cancer Res; 1994 Mar 15; 54(6):1491-6. PubMed ID: 8137253
    [Abstract] [Full Text] [Related]

  • 5. The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
    Skalski V, Feindel W, Panasci LC.
    J Neurooncol; 1989 Jul 15; 7(2):189-93. PubMed ID: 2476532
    [Abstract] [Full Text] [Related]

  • 6. Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.
    Malapetsa A, Bramson JL, Noë AJ, Panasci LC.
    Cancer Chemother Pharmacol; 1992 Jul 15; 31(2):146-50. PubMed ID: 1280536
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity.
    Noë AJ, Marcantonio D, Barton J, Malapetsa A, Panasci LC.
    Biochem Pharmacol; 1996 Jun 28; 51(12):1639-48. PubMed ID: 8687479
    [Abstract] [Full Text] [Related]

  • 8. SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity.
    Panasci LC, Marcantonio D, Noë AJ.
    Cancer Chemother Pharmacol; 1996 Jun 28; 37(6):505-8. PubMed ID: 8612302
    [No Abstract] [Full Text] [Related]

  • 9. Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro.
    Goldenberg GJ, Lee M, Lam HY, Begleiter A.
    Cancer Res; 1977 Mar 28; 37(3):755-60. PubMed ID: 837375
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of L-thyroxine transport into hepatocytes isolated from juvenile rainbow trout (Oncorhynchus mykiss).
    Riley WW, Eales JG.
    Gen Comp Endocrinol; 1993 Apr 28; 90(1):31-42. PubMed ID: 8504920
    [Abstract] [Full Text] [Related]

  • 14. A multicomponent analysis of amino acid transport systems in human lymphocytes. 1. Kinetic parameters of the A and L systems and pathways of uptake of naturally occurring amino acids in blood lymphocytes.
    Segel GB, Simon W, Lichtman MA.
    J Cell Physiol; 1983 Sep 28; 116(3):372-8. PubMed ID: 6604062
    [Abstract] [Full Text] [Related]

  • 15. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
    Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R.
    J Nucl Med; 1999 Aug 28; 40(8):1367-73. PubMed ID: 10450690
    [Abstract] [Full Text] [Related]

  • 16. Transport of L-arginine in cultured glial cells.
    Schmidlin A, Wiesinger H.
    Glia; 1994 Jul 28; 11(3):262-8. PubMed ID: 7960030
    [Abstract] [Full Text] [Related]

  • 17. The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man.
    Skalski V, Rivas J, Panasci L, McQuillan A, Feindel W.
    Cancer Chemother Pharmacol; 1988 Jul 28; 22(2):137-40. PubMed ID: 3409444
    [Abstract] [Full Text] [Related]

  • 18. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
    Huynh H, Nguyen TH, Panasci L, Do P.
    Cancer; 2004 Dec 15; 101(12):2881-91. PubMed ID: 15529313
    [Abstract] [Full Text] [Related]

  • 19. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
    Chen ZP, Remack J, Brent TP, Mohr G, Panasci LC.
    Clin Cancer Res; 1999 Dec 15; 5(12):4186-90. PubMed ID: 10632359
    [Abstract] [Full Text] [Related]

  • 20. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY, Rogers PM, Kelland LR.
    Clin Cancer Res; 1995 Sep 15; 1(9):981-9. PubMed ID: 9816070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.